Family walking with woman on maintenance therapy

Ovarian Cancer


Let’s talk about

ovarian cancer treatment options

If you’ve recently been diagnosed with advanced ovarian cancer, you likely have a lot of questions. As you discuss any future treatment plans with your doctor, it’s important to know the options. Your treatment may include surgery and chemotherapy, and will be individualized based on your specific condition, with the goal of removing or shrinking your tumor.

Husband walking with wife on maintenance therapy

Every person’s ovarian cancer journey is different.

Even if treatment with chemotherapy is successful, many women will still see their cancer come back in their lifetime. This is called recurrence, and it can happen even when it seems like you’re in remission.

The possibility of recurrence can be scary, but understanding what recurrence means—and learning about your treatment options—is a crucial step in taking a more active role in your care.

After your cancer has responded to chemotherapy, one option you have is to watch and wait. This means that your doctor will perform regular tests and exams to look for signs of cancer returning rather than prescribing you medicine.

To help extend the time before cancer returns, another option is maintenance treatment, which is given after a complete or partial response to platinum-based chemotherapy and may offer a chance for more time without cancer recurring.

ZEJULA is approved as a maintenance treatment for women with newly diagnosed ovarian cancer who have responded partially or completely to chemotherapy and women with recurrent germline BRCA-mutated (gBRCAm) ovarian cancer, who respond completely or partially to platinum-based chemotherapy.



It may delay the time without your cancer recurring.*

*In a first-line maintenance clinical trial, ZEJULA delayed disease progression for a median of 14 months vs 8 months with placebo. Results may vary. Median is the middle number in a set of data, also called the midpoint. The trial is ongoing to see if patients live longer overall with treatment.

What could be next?

Learn more about the road ahead.

You’ve been through a lot—from diagnosis to chemotherapy. But there may be more you can do than just watch and wait to see if the cancer comes back.

With maintenance therapy, you can take action after your advanced ovarian cancer has responded to chemotherapy or if you’ve already experienced a recurrence of your germline BRCA-mutated ovarian cancer after responding to chemotherapy.

ZEJULA may be a maintenance treatment option for you if your experience includes:


Being recently diagnosed with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer and having the cancer respond (completely or partially) to treatment with platinum-based chemotherapy



Having your germline BRCA-mutated ovarian, fallopian tube, or primary peritoneal cancer return and responding (completely or partially) to treatment with platinum-based chemotherapy

Frequently Asked

Who should consider ZEJULA?


Things have been challenging lately. Where can I go for support?

See answer

I may need help with access to ZEJULA. Is financial assistance available?

See answer